9BGA
Tri-complex of Daraxonrasib (RMC-6236), KRAS G12C, and CypA
This is a non-PDB format compatible entry.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | CLSI BEAMLINE 08ID-1 |
| Synchrotron site | CLSI |
| Beamline | 08ID-1 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2024-01-19 |
| Detector | DECTRIS PILATUS 6M |
| Wavelength(s) | 0.97946 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 65.560, 81.560, 127.280 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 68.670 - 1.410 |
| R-factor | 0.1886 |
| Rwork | 0.186 |
| R-free | 0.22880 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.005 |
| RMSD bond angle | 0.841 |
| Data reduction software | HKL-2000 |
| Data scaling software | HKL-2000 |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.20.1_4487) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 68.670 | 1.460 |
| High resolution limit [Å] | 1.410 | 1.410 |
| Rmerge | 0.085 | 3.011 |
| Rmeas | 0.089 | 3.131 |
| Rpim | 0.024 | 0.850 |
| Number of reflections | 131773 | 13050 |
| <I/σ(I)> | 13.56 | 0.89 |
| Completeness [%] | 100.0 | 99.87 |
| Redundancy | 13.3 | 13.3 |
| CC(1/2) | 0.999 | 0.339 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 8 | 291 | 28% PEG4000, 0.1 M Tris, pH 8 |






